About the journal
Атеротромбоз is an open-access journal published by «REMEDIUM GROUP» Ltd. in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- «REMEDIUM GROUP» Ltd.
- ISSN
- 2307-1109 · 2658-5952
- Country
- Russia
- Languages
- russian
- Access
- Open access
- Articles in DOAJ
- 258
- Declared review time
- 8 weeks
- Declared peer-review model
- other
- Official website
- https://www.aterotromboz.ru/
Index listings
- DOAJ · 2021-10-04
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2024
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
258
Most recent article
2 years ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
195
Last recorded publication year
2024
h-index
6
i10-index
1
From OpenAlex open data (CC0).
Editorial & policy8
- Last DOAJ review date
- 2021-10-04
- Added to DOAJ
- 2021-10-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 83%
- ORCID iDs in current deposits
- 83%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Atherothrombosis
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
Show all subjects (75)
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Cardiac Arrhythmias and Treatments
- Cardiac Arrhythmias and Treatments
- Aortic aneurysm repair treatments
- Platelet Disorders and Treatments
- Aortic aneurysm repair treatments
- Aortic aneurysm repair treatments
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Abdominal vascular conditions and treatments
- Aortic Disease and Treatment Approaches
- Military Technology and Strategies
- Linguistic, Cultural, and Literary Studies
- Legal and Regulatory Analysis
- Military Technology and Strategies
- Linguistic, Cultural, and Literary Studies
- Legal and Regulatory Analysis
- COVID-19 Clinical Research Studies
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Healthcare Systems and Public Health
- Healthcare Systems and Public Health
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac tumors and thrombi
- Neurological Disorders and Treatments
- Neurological Disorders and Treatments
- Abdominal vascular conditions and treatments
- Peripheral Artery Disease Management
- Peripheral Artery Disease Management
- Peripheral Artery Disease Management
- Abdominal vascular conditions and treatments
- Cardiovascular and Diving-Related Complications
- Blood properties and coagulation
- Lipoproteins and Cardiovascular Health
- Aortic Disease and Treatment Approaches
- Aortic Disease and Treatment Approaches
- Infectious Aortic and Vascular Conditions
- Cerebral Venous Sinus Thrombosis
- Inflammatory Biomarkers in Disease Prognosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Cerebrovascular and Carotid Artery Diseases
- Acute Ischemic Stroke Management
- COVID-19 Clinical Research Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Renal and Vascular Pathologies
- Cerebrovascular and Carotid Artery Diseases
- Acute Ischemic Stroke Management
- COVID-19 Clinical Research Studies
- Blood Pressure and Hypertension Studies
- Renal and Vascular Pathologies
- Renal and Vascular Pathologies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Aortic Thrombus and Embolism
- Vascular Procedures and Complications
- Vascular Procedures and Complications
- Chemotherapy-induced cardiotoxicity and mitigation
- Coronary Interventions and Diagnostics
- Chemotherapy-induced cardiotoxicity and mitigation
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
Keywords (DOAJ)
- atherosclerosis
- acute coronary syndrome
- acute cerebrovascular disorder
- antithrombotic therapy
- anticoagulants
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ